Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
774 studies found for:    pharmacogenomics OR pharmacogenetics
Show Display Options
Rank Status Study
21 Unknown  Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention:
22 Recruiting Pharmacogenetic Decision Support IT System for Psychiatric Hospitalization: RCT
Condition: Major Depressive Disorder
Intervention: Other: Genotype-guided care
23 Suspended Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain
Condition: Chronic Pain
Interventions: Drug: Morphine;   Drug: Oxycodone;   Drug: Fentanyl;   Drug: Buprenorphine
24 Completed Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia
Conditions: Pregnancy;   Cesarean Delivery;   General Anesthesia
Intervention: Drug: Remifentanil
25 Active, not recruiting Medication Therapy Management With Pharmacogenetic Testing
Conditions: Pharmacogenetics;   Medication Therapy Management
Intervention: Other: MTM with PGx
26 Withdrawn Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Cisplatin;   Drug: Cetuximab
27 Recruiting Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate
Condition: Pharmacogenetic Study
Intervention: Drug: Abiraterone Acetate
28 Unknown  Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype
Condition: Depression
Intervention: Drug: antidepressants
29 Completed CYP2D6 Pharmacogenetics in Risperidone-Treated Children
Conditions: Psychiatric Disorders;   Neurodevelopmental Disorders
Intervention:
30 Recruiting EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients
Condition: HIV Infection
Intervention: Drug: Efavirenz
31 Completed
Has Results
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
Conditions: Idiopathic Growth Hormone Deficiency;   Turner Syndrome
Intervention: Other: Blood sampling
32 Recruiting Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
Conditions: Depression;   Adverse Reaction to Drug
Interventions: Drug: SSRI class antidepressant;   Drug: non-SSRI class antidepressant
33 Completed Pharmacogenomic Research in Korean Patients With Hepatitis C
Condition: Chronic Hepatitis C
Intervention:
34 Completed Pharmacogenetic-Directed Treatment for Major Depression
Condition: Depression
Interventions: Behavioral: GeneSightRx;   Behavioral: Treatment as usual
35 Recruiting Pharmacogenetic Study of Mirtazapine Response in Depressed Patients
Condition: Depression
Intervention: Drug: Mirtazapine
36 Completed Paracetamol and Pharmacogenetic
Condition: Healthy
Intervention: Drug: Paracetamol (drug)
37 Recruiting Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity
Conditions: Atrial Fibrillation;   Thrombus Due to Heart Valve Prosthesis
Intervention: Drug: Warfarin
38 Recruiting Pharmacology of Adjuvant Hormonotherapy in Breast Cancer
Condition: Hormono-depending Adjuvant Breast Cancer
Intervention: Drug: Tamoxifen, Letrozole, Anastrozole or Exemestane
39 Enrolling by invitation Pharmacogenetics to Predict Drug Interactions in Kidney Transplant Recipients
Condition: Kidney Transplantation
Interventions: Drug: Tacrolimus + Ketoconazole;   Drug: Tacrolimus alone
40 Unknown  Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years